SLC7A5 and SLC3A2

  • Number of citations of the paper that reports this interaction (PMID 9829974)
  • 32
  • Data Source:
  • HPRD (in vitro)

SLC7A5

SLC3A2

Gene Name solute carrier family 7 (amino acid transporter light chain, L system), member 5 solute carrier family 3 (amino acid transporter heavy chain), member 2
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 1 interactors: SLC3A2 11 interactors: EGFR FAM57A HNRNPD ICAM1 ITGB1 SLC7A10 SLC7A11 SLC7A5 SLC7A7 SLC7A8 VHL
Entrez ID 8140 6520
HPRD ID 02552 01148
Ensembl ID ENSG00000103257 ENSG00000168003
Uniprot IDs Q01650 J3KPF3 P08195
PDB IDs 2DH2 2DH3
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aldh1a1  anxa1  bcar1  cldn1  crmp1  endpoint  folr1  foxm1  il12rb2  il7r  inconclusive  kiaa1524  lox  mcm7  mta1  mtdh  ncoa3  ndrg2  nedd9  nes  overview  pbk  ppm1d  principally  prognostication  qualifying  sqstm1  warranted  wnt1 
adenocarcinoma  anchorage  approved  braf  cd74  consisting  constitutively  driver  druggable  erbb4  exclusively  ezr  fusion  fusions  her3  ima  imas  kiaa1468  kras  mucinous  mutually  nih3t3  nrg1  oncogenic  ret  sequencing  transcriptome  trim24  tumorigenicity 
Tagcloud (Difference) ?
aldh1a1  anxa1  bcar1  cldn1  crmp1  endpoint  folr1  foxm1  il12rb2  il7r  inconclusive  kiaa1524  lox  mcm7  mta1  mtdh  ncoa3  ndrg2  nedd9  nes  overview  pbk  ppm1d  principally  prognostication  qualifying  sqstm1  warranted  wnt1 
adenocarcinoma  anchorage  approved  braf  cd74  consisting  constitutively  driver  druggable  erbb4  exclusively  ezr  fusion  fusions  her3  ima  imas  kiaa1468  kras  mucinous  mutually  nih3t3  nrg1  oncogenic  ret  sequencing  transcriptome  trim24  tumorigenicity 
Tagcloud (Intersection) ?